{"blog": [], "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "Y"}], "web_url": "http://www.nytimes.com/2016/05/17/business/valeant-pharmaceuticals-expands-drug-discount-offer-after-criticism.html", "document_type": "article", "byline": {"person": [{"lastname": "THOMAS", "firstname": "Katie", "role": "reported", "organization": "", "rank": 1}], "original": "By KATIE THOMAS"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/05/17/business/17valeant/17valeant-thumbWide.jpg", "legacy": {"wide": "images/2016/05/17/business/17valeant/17valeant-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/05/17/business/17valeant/17valeant-articleLarge.jpg", "legacy": {"xlarge": "images/2016/05/17/business/17valeant/17valeant-articleLarge.jpg", "xlargeheight": "393", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 393}, {"url": "images/2016/05/17/business/17valeant/17valeant-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/05/17/business/17valeant/17valeant-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "835", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The company said hospitals would be eligible for a discount of 10 percent to 40 percent on the heart drugs Nitropress and Isuprel.", "pub_date": "2016-05-17T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Valeant Expands Drug Discount Offer After Criticism", "main": "Valeant Pharmaceuticals Expands Drug Discount Offer After Criticism"}, "print_page": "3", "snippet": "The company said hospitals would be eligible for a discount of 10 percent to 40 percent on the heart drugs Nitropress and Isuprel.", "_id": "5739e16738f0d83bc1f16560", "slideshow_credits": null, "abstract": "Valeant Pharmaceuticals International unveils new plan that simplifies and expands its previous discount program for two heart medications, Nitropress and Isuprel; announcement follows Congressional hearings on complaints firm failed in its 2015 pledge to give price cuts to hospitals and large purchasers."}